Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients With Chronic Myeloid Leukemia
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
Evaluation of the efficacy and safety of withdrawal of tyrosine kinase inhibitors after
previous two-step dose reduction in patients with chronic myeloid leukemia in deep molecular
remission